Regulus Therapeutics
RGLS
#8961
Rank
โ‚ฌ99.02 M
Marketcap
1,49ย โ‚ฌ
Share price
7.33%
Change (1 day)
-43.87%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚ฌ0.25 Million

According to Regulus Therapeutics's latest financial reports the company's total debt is โ‚ฌ0.25 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.26 M-87.82%
2023-12-31โ‚ฌ2.16 M-63.08%
2022-12-31โ‚ฌ5.85 M-6.5%
2021-12-31โ‚ฌ6.26 M65.53%
2020-12-31โ‚ฌ3.78 M-71.04%
2019-12-31โ‚ฌ13.06 M-9.86%
2018-12-31โ‚ฌ14.48 M-12.46%
2017-12-31โ‚ฌ16.55 M-12.08%
2016-12-31โ‚ฌ18.82 M
2014-12-31โ‚ฌ19.23 M135.55%
2013-12-31โ‚ฌ8.16 M6.61%
2012-12-31โ‚ฌ7.66 M-0.51%
2011-12-31โ‚ฌ7.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ19.79 B 7,779,425.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ17.30 B 6,800,374.45%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ6.15 B 2,419,717.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.96 B 10,990,410.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.20 B 472,910.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.38 M 11,055.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.53 B 18,686,031.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA